JOB DETAILS:

..

1.      Purpose of consultancy

General objective:

This activity aims to generate pharmaceutical expenditure by estimating aggregate and disaggregated health expenditure from pharmaceutical expenditure.  Four selected technical assistants (TAs) are expected to assist the Center for Health Financing and Decentralization Policy (Pusjak PDK) in analyzing, and processing pharmaceutical expenditure data, and generating pharmaceutical expenditure within the agreed period.

Specific objectives:

1)     Provide input to adjust the Health Accounts methodology in producing more quality and detailed pharmaceutical expenditure data in Indonesia.

2)     Determine how different pharmaceutical expenditures can be collected, structured, and classified to align with the Health Accounts methodology.

3)     Identify the types of pharmaceutical expenditure data that are most useful to decision-makers in Indonesia; and early efforts to collect, analyze, and package pharmaceutical expenditure data to meet the needs of pharmaceutical decision-makers.

4)     Tracking pharmaceutical expenditure will include national data targeting available secondary data sources

5)     Assist and support the Center for Health Financing and Decentralization Policy in holding meetings/workshops related to Health Accounts activities and providing progress reports on these activities.

2.      Background  

One of the policy directions and strategies in the RPJMN 2020-2024 is to improve access and quality of health services towards Universal Health Coverage (UHC) which focuses on strengthening basic health services. It explicitly states that strengthening health systems and controlling drugs and food are priorities.

The importance of generating pharmaceutical expenditure for Indonesia is to achieve Universal Health Coverage (UHC). This is related to the amount of pharmaceutical availability, production, and distribution required as one of the components for providing health services. Accountable data on pharmaceutical expenditure will be beneficial for evidence-based health policies in the era of National Health Insurance.

Currently, pharmacy expenditure tracking will enable health policymakers to gain an overview of pharmaceutical expenditure patterns and improve system-wide planning and resource allocation to improve efficiency and accountability.

3.      Deliverables

1)     Report on the capacity building of pharmaceutical expenditure tracking.

2)     Report on pharmaceutical expenditure 2023 and 2024.

3)     User guide of pharmaceutical expenditure.

4.      Qualifications, experience, skills and languages

Educational Qualifications:

Essential: A bachelor’s degree in Public Health, particularly health economics, health financing, or health policy

Desirable: –

Experience

Essential:

1)     At least 2 years of working experience in Health Accounts, especially pharmaceutical expenditure production as per SHA 2011 methodology;

2)     Pharmaceutical expenditure data collection and management;

3)     Data analysis.

Desirable: –

Skills/Knowledge: 

1)     Strong academic theoretical knowledge, expertise, and technical experience in the field of Health Accounts, especially in the production of pharmaceutical expenditure.

2)     Have experience performing NHA estimation and pharmaceutical expenditure.

3)     A good track record in previous projects with the Ministry of Health, other development partners, and other national and local governments.

Languages and level required (Basic/Intermediate/Advanced):

Intermediate level of English.

5.      Location

On site: Consultant will cooperate with the Center for Health Financing and Decentralization Policy at the office of the Ministry of Health of the Republic of Indonesia or a regulated place for Health Accounts-related activities

6.      Travel

N/A

7.      Remuneration and budget (travel costs are excluded):

a.      Remuneration: IDR 22,000,000 monthly

b.      Living expenses (A living expense is payable to on-site consultants who are internationally recruited): N/A

c.      Expected duration of contract: 13 months

Additional Information:

• This vacancy notice may be used to identify candidates for other similar consultancies at the same level.

• Only candidates under serious consideration will be contacted.

• A written test may be used as a form of screening.

• If your candidature is retained for interview, you will be required to provide, in advance, a scanned copy of the degree(s)/diploma(s)/certificate(s) required for this position. WHO only considers higher educational qualifications obtained from an institution accredited/recognized in the World Higher Education Database (WHED), a list updated by the International Association of Universities (IAU)/United Nations Educational, Scientific and Cultural Organization (UNESCO). The list can be accessed through the link: http://www.whed.net/. Some professional certificates may not appear in the WHED and will require individual review.

• For information on WHO’s operations please visit: http://www.who.int.

• WHO is committed to workforce diversity.

• WHO has a smoke-free environment and does not recruit smokers or users of any form of tobacco.

• Applications from women and from nationals of non and underrepresented Member States are particularly encouraged.

·        WHO prides itself on a workforce that adheres to the highest ethical and professional standards and that is committed to put the WHO Values Charter into practice.

• WHO has zero tolerance towards sexual exploitation and abuse (SEA), sexual harassment and other types of abusive conduct (i.e., discrimination, abuse of authority and harassment). All members of the WHO workforce have a role to play in promoting a safe and respectful workplace and should report to WHO any actual or suspected cases of SEA, sexual harassment and other types of abusive conduct. To ensure that individuals with a substantiated history of SEA, sexual harassment or other types of abusive conduct are not hired by the Organization, WHO will conduct a background verification of final candidates.

• Consultants shall perform the work as independent contractors in a personal capacity, and not as a representative of any entity or authority. The execution of the work under a consultant contract does not create an employer/employee relationship between WHO and the Consultant.

• WHO shall have no responsibility whatsoever for any taxes, duties, social security contributions or other contributions payable by the Consultant. The Consultant shall be solely responsible for withholding and paying any taxes, duties, social security contributions and any other contributions which are applicable to the Consultant in in each location/jurisdiction in which the work hereunder is performed, and the Consultant shall not be entitled to any reimbursement thereof by WHO.

Qualifications

..

1.      Purpose of consultancy

General objective:

This activity aims to generate pharmaceutical expenditure by estimating aggregate and disaggregated health expenditure from pharmaceutical expenditure.  Four selected technical assistants (TAs) are expected to assist the Center for Health Financing and Decentralization Policy (Pusjak PDK) in analyzing, and processing pharmaceutical expenditure data, and generating pharmaceutical expenditure within the agreed period.

Specific objectives:

1)     Provide input to adjust the Health Accounts methodology in producing more quality and detailed pharmaceutical expenditure data in Indonesia.

2)     Determine how different pharmaceutical expenditures can be collected, structured, and classified to align with the Health Accounts methodology.

3)     Identify the types of pharmaceutical expenditure data that are most useful to decision-makers in Indonesia; and early efforts to collect, analyze, and package pharmaceutical expenditure data to meet the needs of pharmaceutical decision-makers.

4)     Tracking pharmaceutical expenditure will include national data targeting available secondary data sources

5)     Assist and support the Center for Health Financing and Decentralization Policy in holding meetings/workshops related to Health Accounts activities and providing progress reports on these activities.

2.      Background  

One of the policy directions and strategies in the RPJMN 2020-2024 is to improve access and quality of health services towards Universal Health Coverage (UHC) which focuses on strengthening basic health services. It explicitly states that strengthening health systems and controlling drugs and food are priorities.

The importance of generating pharmaceutical expenditure for Indonesia is to achieve Universal Health Coverage (UHC). This is related to the amount of pharmaceutical availability, production, and distribution required as one of the components for providing health services. Accountable data on pharmaceutical expenditure will be beneficial for evidence-based health policies in the era of National Health Insurance.

Currently, pharmacy expenditure tracking will enable health policymakers to gain an overview of pharmaceutical expenditure patterns and improve system-wide planning and resource allocation to improve efficiency and accountability.

3.      Deliverables

1)     Report on the capacity building of pharmaceutical expenditure tracking.

2)     Report on pharmaceutical expenditure 2023 and 2024.

3)     User guide of pharmaceutical expenditure.

4.      Qualifications, experience, skills and languages

Educational Qualifications:

Essential: A bachelor’s degree in Public Health, particularly health economics, health financing, or health policy

Desirable: –

Experience

Essential:

1)     At least 2 years of working experience in Health Accounts, especially pharmaceutical expenditure production as per SHA 2011 methodology;

2)     Pharmaceutical expenditure data collection and management;

3)     Data analysis.

Desirable: –

Skills/Knowledge: 

1)     Strong academic theoretical knowledge, expertise, and technical experience in the field of Health Accounts, especially in the production of pharmaceutical expenditure.

2)     Have experience performing NHA estimation and pharmaceutical expenditure.

3)     A good track record in previous projects with the Ministry of Health, other development partners, and other national and local governments.

Languages and level required (Basic/Intermediate/Advanced):

Intermediate level of English.

5.      Location

On site: Consultant will cooperate with the Center for Health Financing and Decentralization Policy at the office of the Ministry of Health of the Republic of Indonesia or a regulated place for Health Accounts-related activities

6.      Travel

N/A

7.      Remuneration and budget (travel costs are excluded):

a.      Remuneration: IDR 22,000,000 monthly

b.      Living expenses (A living expense is payable to on-site consultants who are internationally recruited): N/A

c.      Expected duration of contract: 13 months

Additional Information:

• This vacancy notice may be used to identify candidates for other similar consultancies at the same level.

• Only candidates under serious consideration will be contacted.

• A written test may be used as a form of screening.

• If your candidature is retained for interview, you will be required to provide, in advance, a scanned copy of the degree(s)/diploma(s)/certificate(s) required for this position. WHO only considers higher educational qualifications obtained from an institution accredited/recognized in the World Higher Education Database (WHED), a list updated by the International Association of Universities (IAU)/United Nations Educational, Scientific and Cultural Organization (UNESCO). The list can be accessed through the link: http://www.whed.net/. Some professional certificates may not appear in the WHED and will require individual review.

• For information on WHO’s operations please visit: http://www.who.int.

• WHO is committed to workforce diversity.

• WHO has a smoke-free environment and does not recruit smokers or users of any form of tobacco.

• Applications from women and from nationals of non and underrepresented Member States are particularly encouraged.

·        WHO prides itself on a workforce that adheres to the highest ethical and professional standards and that is committed to put the WHO Values Charter into practice.

• WHO has zero tolerance towards sexual exploitation and abuse (SEA), sexual harassment and other types of abusive conduct (i.e., discrimination, abuse of authority and harassment). All members of the WHO workforce have a role to play in promoting a safe and respectful workplace and should report to WHO any actual or suspected cases of SEA, sexual harassment and other types of abusive conduct. To ensure that individuals with a substantiated history of SEA, sexual harassment or other types of abusive conduct are not hired by the Organization, WHO will conduct a background verification of final candidates.

• Consultants shall perform the work as independent contractors in a personal capacity, and not as a representative of any entity or authority. The execution of the work under a consultant contract does not create an employer/employee relationship between WHO and the Consultant.

• WHO shall have no responsibility whatsoever for any taxes, duties, social security contributions or other contributions payable by the Consultant. The Consultant shall be solely responsible for withholding and paying any taxes, duties, social security contributions and any other contributions which are applicable to the Consultant in in each location/jurisdiction in which the work hereunder is performed, and the Consultant shall not be entitled to any reimbursement thereof by WHO.

ABSTRACT:

World Health Organization National Technical Consultant – Pharmaceutical Expenditure Indonesia WHO Jobs 2024

World Health Organization looking for “National Technical Consultant – Pharmaceutical Expenditure”. Applicants with an Advanced degree may apply on or before 19-Jul-24.

The World Health Organization has published a job vacancy announcement on 12/07/2024 for qualified applicants to fill in the vacant post of National Technical Consultant – Pharmaceutical Expenditure to be based in Jakarta , Indonesia. For more jobs, please visit https://unjoblink.org

Company Name: World Health Organization

Job Title: National Technical Consultant – Pharmaceutical Expenditure

Duty Station: Jakarta , Indonesia

Country: Indonesia

Application Deadline: 19-Jul-24